Cenntro Inc. (CENN): Nasdaq/NYSE listing notice — Cenntro receives Nasdaq delisting notice for bid price below $1.00

Cenntro Inc.

Notice on April 25, 2025 for failing Minimum Bid Price Requirement (closing below $1.00 for 30 consecutive days).
Company has 180 days, until October 22, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured by Oct 22, may qualify for an additional 180-day period if other listing standards are met.
Company intends to take all reasonable measures to regain compliance; stock continues trading on Nasdaq during cure period.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Cenntro Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 25, 2025 (the “Notification Date”), Cenntro Inc. (the “Company”) received a letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s common stock was below $1.00 per share for thirty consecutive business days. The Notice does not impact the listing of the Company’s common stock on the Nasdaq Capital Market. In accord

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Cenntro Inc. filing history →

Source: SEC EDGAR

accession 0001140361-25-016907

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.